Multimodal diagnostics for keratoconus and ectatic corneal diseases: a paradigm shift.

Authors:
Ambrósio R; Salomão MQ; Barros L; da Fonseca Filho JBR; Guedes J and 5 more

Journal:
Eye Vis (Lond)

Publication Year: 2023

DOI:
10.1186/s40662-023-00363-0

PMCID:
PMC10623885

PMID:
37919821

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Eye Vis (Lond)

Abbreviation: Eye Vis (Lond)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
An in vitro investigation into the impact of corneal rinsing on riboflavin/UVA corneal cross-linkin…
Morgan SR; O'Brart DPS; Huang J and 2 more (2024) - Transparency Score: 3/6
Features of optical coherence tomography angiography in age-related macular degeneration with resid…
Song YY; Seong HJ; Kim JT and 2 more (2024) - Transparency Score: 3/6
Homocysteine and mitochondrial quality control in diabetic retinopathy.
Malaviya P; Kowluru RA. (2024) - Transparency Score: 3/6
Inhibition of miR-542-3p augments autophagy to promote diabetic corneal wound healing.
Liao D; Wei S; Hu J. (2024) - Transparency Score: 3/6
Myopic choroidal neovascularization with neovascular signal around perforating scleral vessel prone…
She X; Yao W; Huang G and 8 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsDr. Ambrósio is a consultant for Oculus, Alcon, Zeiss and Mediphacos. Competing interests Dr. Ambrósio is a consultant for Oculus, Alcon, Zeiss and Mediphacos."

Evidence found in paper:

"Funding Not applicable."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025